The Latest Breaking News from Pfizer

Most parents want their children aged 5-11 to be vaccinated and prefer they receive the Pfizer vaccine produced using mRNA technology, a survey has revealed.

Pfizer Inc (NYSE: PFE) is trading lower Monday after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.

Experts say waiting for data on three doses is the right call.

The FDA says it needs more time to review data on a potential three-dose vaccine for children aged 6 months to four

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday. Though it's now well documented that vaccine efficacy goes down after two doses, relatively little…

China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease. The drug has so far been authorized in about 40 countries including the United States and Israel, while the European…

China has granted emergency approval for a Pfizer Covid-19 pill in a promising sign that the country could open up further to foreign vaccines and treatments for the virus.

China granted emergency approval for Pfizer’s COVID-19 pill in a promising sign the country could open up further to foreign vaccines and treatments for the virus.

Canada to make changes to COVID border restrictions next week, says official